In the high-grade squamous cell carcinomas, the status of p16 immunoreactivity was significantly associated with female gender (P = 0.047) but not with age, location, size, TNM stage, or histological type (Supplementary Table 3). Here, CDKN2A is linked to squamous cell carcinoma.